Treatment and Prevention of CMV Disease in Transplant Recipients: Current Knowledge and Future Perspectives.

J Clin Pharmacol

Center for Drug Evaluation and Research, Office of Antimicrobial Products, Division of Antiviral Products, Food and Drug Administration, Silver Spring, MD, USA.

Published: June 2019

This review summarizes the significant impact of cytomegalovirus (CMV) infection on solid organ and hematopoietic stem cell transplant recipients. A discussion of the various CMV prevention and treatment strategies is provided, including a detailed description of each of the available CMV antiviral drugs.

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcph.1363DOI Listing

Publication Analysis

Top Keywords

transplant recipients
8
treatment prevention
4
cmv
4
prevention cmv
4
cmv disease
4
disease transplant
4
recipients current
4
current knowledge
4
knowledge future
4
future perspectives
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!